NuPathe Inc.
Zecuity® transdermal patch to treat migraine headaches approved by the FDA in 2013. IPO (NASDAQ: PATH) completed in August 2010 and the company was acquired by Teva Pharmaceutical Industries Ltd. in February 2014.
Exited Portfolio Company
